Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sometimes people change their minds. Just like you after you said you would no longer post on this board. Best of Luck! Glad to have you back!
That looks good, the last time I looked I thought it was at 840,000? Did I miss an update?
Post # of 5694
InstaCare Subsidiary Inks 5-Year Exclusive Pact for Distribution of Proprietary Diabetes Test Strip Into $9.8 Billion Testing Market
--
-- COMPANY PROJECTS SIGNIFICANT 3Q 2010 REVENUES AND ANTICIPATES CAPTURE OF 5% MARKET SHARE OF EXPECTED $12 BILLION MARKET BY 2012
Lakes, I guess we don't know what we don't know. Maybe there are more delays with the GenStrip's going to market.
I thought I would add my own speculation since we are all just speculating and have not heard anything directly from the company regarding PSID.
It was originally touted as immediate and substantial revenues for the 3rd quarter, then moved to October. I think we have to wait and see what happens and when. Personally, I will wait for information directly from the company.
Vista, you have been called out. Are you going to click your link and let the complaint fly ? Or just sit by and let the abuse continue?
: Mookie 5 minutes ago Yes Fire!, I had my chat. These people are serious and desperate. They may overpay, but they have very little time to complete some sort of transaction that will bring in revenues and a business direction.
I have three concerns.
1. the price for my shares
2. these people are not healthcare people but they sure think a lot about their own abilities
3. shareholders calling them and in effect creating the wrong "atmosphere"
Vista, you are out of your league and you are piszsing me off with your flipper conspiracy mentality. It is not wise to pisz me off. Ask DC. Rating :
(No ratings)Rate it:
Value, a good investor is always curious and somewhat skeptical. Yes, there are times that some of the questions might not be able to be answered on certain forums, but that certainly doesn’t diminish the value of the question. That’s somewhat like telling a football player that he doesn’t need to lift weights because he only needs to knock people down and tackle.
I’m not a big fan of calling companies and asking questions because I have found from past experience that companies are usually overly optimistic, and rightfully so. In fact, most entrepreneurial people are overly optimistic by their very nature. I imagine if not for optimistic people very few companies would be started.
I think the bigger question surrounds managing expectations. One method to get a handle on this is to go back and read every report and PR that the company has issued. Once you read these you can then see what was planned, projected, expected, etc., and then you can compare this with actual results. This will give you a general idea of the company’s track record and provide you a basis for interpreting new information as it is presented.
I find that is also useful to go back and read old posts from message boards as this will give you an idea of how investor sentiment was influenced by company pronouncements. You might also be surprised to find out that some posters have been promoting a stock for many years. This provides insight into others perspectives and allows you to properly filter the posts that are made.
All IMO
Value, I had some of the same questions. They were listed as pre-sales over a 12 month period. I don’t think that means they have purchase orders in hand as the product is not shipping yet. I think the main take away is that there is substantial interest in the product. At this point with the information provided I think it’s a little premature to get the calculator out and start running guesses. I don’t see ISCR moving until the numbers show up in the financials; it seems like a “show me” stock. That should change if the company continues to make progress. As far as showing the world the new product, I think the main method will be to utilize distributors who have experience selling into this market. IMO
VV, thanks for the response. I first invested in ISCR about a year ago. I was on a consulting engagement in the US and worked with a company (non public) that distributes diabetes supplies. That company grew to 50 million in sales virtually overnight.
So I hope we're right about little ISCR.
Good Luck!
Thoughts on what it will take for some volume and the PPS to move up ? ISCR seemingly puts out good PR's and info, but there doesn't seem to be much interest. I think that if they continue to execute we will see some movement based on actually results in the next quarter or two. But it doesn't look like the market has calculated future expectations into the PPS.(or have they)
Do you think it's because ISCR is still unknown to investors, or is something else going on? ALL IMO
Kitju63, I agree. The flipper, basher nonsense gets tiring real quick. I am hoping that things continue to go well for ISCR.
VV, your post makes alot of sense, but I do think that they need to move quickly as the pace of things imo are starting to pick up rapidly.
An unreliable source has indicated that Genstrip presales will be posted on the website no later than Tuesday. Please be aware that this information is very unreliable, but perhaps we are in for a pleasant surprise.
Ksviking12, I have been investing in penny stocks for many years and I have also worked with many small public companies trying to get to the next step. Often, the company is an extreme passion, dream of the founder. And actually it is often this passion and determination that allows them to succeed-that's a good thing. The bad side can be that they will always present things in the best possible light-so the information might not be that objective. You've heard the expression-fake it till you make it.
Surely, you can find many examples of less than forthright communications from penny stock companies. I believe that ISCR is not the kind of company to purposely mislead investors, but it is possible that their determination and passion allows them to be overly optimistic. An example would be the AMEX listing that everyone was expecting to already happen.
For me, the next critical milestone is increasing sales and getting as close to the updated guidance for 2010 as possible.
Also, if I have questions, it is likely that others not invested in ISCR(but considering) may also have the same questions. ALL IMO
Does anyone understand the magic (for lack of a better word) that will allow Genstrips to be sold at such a low price? Different materials? Revolutionary manufacturing Process? Cutting out the middle man?
Does anyone know anything about Shasta or Broadtree? I was a little alarmed at the Shasta website.
I am sincerely interested in opinions on these subjects.
Just to reiterate, I am long this stock because of the distribution side of the business (which seems to be improving) without consideration for EHR and GenStrips.
I would appreciate hearing from others on these topics.
Thanks
Mr. Sensitivity,
It is sad to see you go. I was hoping that you could share some of your knowledge about ISCR. Perhaps you will change your mind and come back. I know we don't see eye to eye on all the issues, but I was hoping an honest and open presentation/sharing of ideas would be beneficial to everyone. Either way, I wish you all the best with your investment in ISCR.
Premonition12
A recent 1.3 billion dollar merger of 2 EHR companies:
The combined client base will include 180,000 physicians, 1,500 hospitals and 10,000 post-acute care organizations.
Another EHR provider claims that 170,000 doctors will utilize their system after the completion of their current rollouts.
Survey: 85 percent of HIT professionals planning EHR implementation by end of 2011
I believe that time is of the essence for ISCR to rollout their EHR software.
Selling software requires an infrastucture at a minimum including:
1. A sales Team that understands the clients processes and needs.
2. Team members that are experts capable of presnting and demonstrating the software.
3. A consulting team that has the technical knowledge to configure and install the software.
4. A technical support team to address on going issues/problems.
5. A development team to address customizations and specific needs(integrations/customizations, etc.) of clients.
This type of infrastructure cannot be developed overnight, and would be almost impossible to buy. In my opinion, this represents a competitive disadvantage to ISCR. Others hace years of experience selling software applications into this market. They have name recognition and have built solid reputations. Even if the ISCR product is better, high adoption might be difficuly to obtain. This is especially true if companies have already made significant capital outlays. I believe time is of the essence.
Thank you for your reply.
Are you willing to discuss ISCR positive points as it relates to EHR? I am open to the discussion. Since you have been a shareholder for a long time I assume you know alot about the company and MD@hand, etc. What do you think about the competitive landscape? Do you have any information on possible partners?
Thank you in advance!
Your guess is as good as mine. Everything has both pro's and con's, and the discussion of both provides an opportunity to develop a well rounded viewpoint. I for one am open to discussions as I certainly do not know everything. I find that being open to new ideas allows me to continue to learn and grow. For example, I am open to a civil discussion with you as to why you feel that ISCR is positioned for success in the EHR arena.
VV, Fair Enough.
The reason I came over to this board was that I was hoping to openly discuss ISCR both pro and con without being attacked. I appreciate your removal of the offending posts and hope that a healthy discussion can flourish on this board.
VV, I have kept all of my posts respectful, civil and I have not accused anyone of anything. Nor have I demonized anyone, to the contrary both my posts and myself have been bashed. If this is not correct, please let me know where I demonized or was disrespectful.
As far as mentioning other companies, I thought that looking at the competition would be a relevant topic for an investment message board. ISCR does not stand in a vacuum. Some of the competition is not small and are already selling products.
My posts and discussions were with the intent of learning more about ISCR, not to be bashed.
I agree about the distribtion side of the business, good things seem to be happening. IMO
For the record, I am long ISCR. I have numerous concerns on the EMR side of the business and was hoping to have an intelligent dialogue. I am smart enough to know I don't know everything and I am open to the ideas of others.
I am invested in ISCR for the distribution side of the business and in my opinion recent results have been encouraging. Revenues increasing, margins creeping up, balance sheet being cleaned up. If they can meet the updated guidance for 2010 I think that will provide positive results in terms of the PPS.
V, thanks for the reply. I was aware of 9/20. I apologize for my post, I was not inquiring of HHS certification only. Many companies have taken advantage of CCHIT certifications to add credibility to their products.
My concern is that ISCR has been talking about EMR for many years, but it seems that not alot has happened. This market is very competitive.
I know you are very big fan of ISCR, I am interested in your thoughts as to why ISCR will be successful with EMR.
Dear Mr. Sensitivity,
I do not bash ISCR, I am a shareholder with some doubts. Do you know the status of their emr certifications?
Anyone know the status of the certification?
http://www.cchit.org/
Thoughts ?
http://genstrip.com/
Doggie, please explain how rising accounts receivables and rising inventory levels are positive.
Doggie, did you read the quarterly report. Sales of GenStrips are projected to start in October. Projecting more than 30m in 2011.